Organization | Vietstar Biomedical Research

Vietstar Biomedical Research Report issue

For profit Phase 2 Phase 3

Founded: Hanoi Vietnam (1996)

Organization Overview

First Clinical Trial

2016

NCT02798159

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2022

Timeline

NOW

Now

Alternative names

Vietstar Biomedical Research

Active Ingredients

Drugs in Phase 3 Trials (5)

docetaxel (taxotere) (2 trials)

inactivated influenza vaccine (1 trial)

sildenafil (viagra) (1 trial)

td0025 (1 trial)

trastuzumab (herceptin) (2 trials)

Drugs in Phase 2 Trials (1)

TD0069 (1 trial)

Drugs in Other Trials (4)

10-valent Pneumococcal Conjugate Vaccine (Pneumosil) (1 trial)

glucosamine (1 trial)

hybrid 5 component dtap, vero ipv, hep b and prp-ompc (1 trial)

polycan (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Erectile Dysfunction (Phase 3)

Overview

Highest Phase: Phase 3
# of Trials: 8
# of Trial APIs: 10